down arrow

Concord Biotech

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE338H01029
  • NSEID: CONCORDBIO
  • BSEID: 543960
INR
1,660.00
59.35 (3.71%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 68.17 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Rs cr
Consolidate Half Yearly Results
Sep'24
Sep'23
Sep'22
Net Sales
525.98
457.17
339.90
Other Operating Income
0.00
0.00
0.00
Total Operating income
525.98
457.17
339.90
Raw Material Cost
123.09
81.48
80.37
Purchase of Finished goods
33.48
22.07
11.70
(Increase) / Decrease In Stocks
-31.95
-10.28
-17.93
Employee Cost
65.33
58.42
54.05
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
118.08
114.14
109.16
Total Expenditure (Excl Depreciation)
308.03
265.83
237.35
Operating Profit (PBDIT) excl Other Income
217.95
191.34
102.55
Other Income
20.33
14.78
13.86
Operating Profit (PBDIT)
238.28
206.12
116.41
Interest
0.34
1.59
2.15
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
237.94
204.53
114.26
Depreciation
26.49
26.34
26.08
Profit Before Tax
211.46
178.19
88.18
Tax
54.52
45.23
22.64
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
156.93
132.96
65.55
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
156.93
132.96
65.55
Share in Profit of Associates
-1.60
2.55
5.68
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
155.33
135.51
71.23
Equity Capital
10.46
10.46
10.46
Face Value
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
14.85
12.96
0.68
Diluted Earnings per share
14.85
12.95
6.81
Operating Profit Margin (Excl OI)
41.44%
41.85%
30.17%
Gross Profit Margin
45.24%
44.74%
33.62%
PAT Margin
29.53%
29.64%
20.96%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2024 is 15.05% vs 34.50% in Sep 2023

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2024 is 14.63% vs 90.24% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2024 is 13.91% vs 86.58% in Sep 2023

stock-summary

Interest

Growth in half year ended Sep 2024 is -78.62% vs -26.05% in Sep 2023

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2024 has fallen from Sep 2023

Compare Half Yearly Results Of Concord Biotech With
Markets Mojo
Figures in Rs cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
525.98
5,969.93
-5,443.95
-91.19%
Other Operating Income
0.00
0.00
0.00
Total Operating income
525.98
5,969.93
-5,443.95
-91.19%
Raw Material Cost
123.09
934.97
-811.88
-86.83%
Purchase of Finished goods
33.48
857.27
-823.79
-96.09%
(Increase) / Decrease In Stocks
-31.95
-104.82
72.87
69.52%
Employee Cost
65.33
1,280.21
-1,214.88
-94.90%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
118.08
1,470.50
-1,352.42
-91.97%
Total Expenditure (Excl Depreciation)
308.03
4,438.13
-4,130.10
-93.06%
Operating Profit (PBDIT) excl Other Income
217.95
1,531.80
-1,313.85
-85.77%
Other Income
20.33
210.03
-189.70
-90.32%
Operating Profit (PBDIT)
238.28
1,741.83
-1,503.55
-86.32%
Interest
0.34
18.01
-17.67
-98.11%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
237.94
1,723.82
-1,485.88
-86.20%
Depreciation
26.49
213.36
-186.87
-87.58%
Profit Before Tax
211.46
1,510.46
-1,299.00
-86.00%
Tax
54.52
314.99
-260.47
-82.69%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
156.93
1,195.47
-1,038.54
-86.87%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
156.93
1,195.47
-1,038.54
-86.87%
Share in Profit of Associates
-1.60
6.48
-8.08
-124.69%
Minority Interest
0.00
-11.99
11.99
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
155.33
1,189.96
-1,034.63
-86.95%
Equity Capital
10.46
40.06
-29.60
-73.89%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
14.85
29.70
-14.85
-50.00%
Diluted Earnings per share
14.85
29.65
-14.80
-49.92%
Operating Profit Margin (Excl OI)
41.44%
25.66%
0.00
15.78%
Gross Profit Margin
45.24%
28.88%
0.00
16.36%
PAT Margin
29.53%
20.13%
0.00
9.40%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 525.98 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 15.05% vs 34.50% in Sep 2023

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 155.33 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 14.63% vs 90.24% in Sep 2023

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 217.95 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 13.91% vs 86.58% in Sep 2023

Half Yearly - Interest
Interest 0.34 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is -78.62% vs -26.05% in Sep 2023

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 41.44%
in Sep 2024

Figures in Rs %
stock-summary

Growth in half year ended Sep 2024 has fallen from Sep 2023